High urgency

FTC Sues to Stop Amare Global Holdings from Misrepresenting the Health Benefits of Its Dietary Supplements for Children and Adults

Detected July 7, 2026 · in Dietary-Supplement Labeling (FDA)

FTC sues Amare Global Holdings for deceptive health claims on dietary supplements, signaling increased enforcement against misleading marketing.

Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 7, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately; ongoing compliance required.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

FTC filed a lawsuit against Amare Global for misrepresenting health benefits of supplements, including unsubstantiated claims for children and adults.

Who it affects

Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers

What you must do

Review all product claims (structure/function, health, and disease claims) to ensure they are substantiated by competent and reliable scientific evidence.

Deadline

Immediately; ongoing compliance required.

Source: https://www.ftc.gov/news-events/news/press-releases/2026/06/ftc-sues-stop-amare-global-holdings-misrepresenting-health-benefits-its-dietary-supplements-children

Never miss a change like this again

Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Dietary-Supplement Labeling (FDA)